Dr. Pestana Knight is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 216-445-6739Fax+1 216-445-4378
Summary
- Dr. Elia Pestana Knight is a child epileptologist based in Cleveland, Ohio. She enriched her expertise through fellowships and residencies at the University of Michigan Health System, Children's Hospital of Michigan, Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens Hospital and Cleveland Clinic. Dr. Pestana Knight specializes in medically refractory pediatric epilepsy and developmental and epileptic encephalopathy. She has contributed significantly to her field with several publications in notable medical journals like Epilepsia, Neurology, Lancet Neurology, Epileptic Disorders, Epilepsy Research, and Journal of Neurodevelopmental Disorders, etc. Many of her papers have been frequently cited, reflecting their relevance to her field.
Education & Training
- University of MichiganResidency, Child Neurology, 2007 - 2010
- University of MichiganFellowship, Child Neurology, 2010
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 2005 - 2007
- Children's Hospital of MichiganResidency, Pediatrics, 2004 - 2005
- Cleveland Clinic FoundationFellowship, Epilepsy, 1999 - 2004
Certifications & Licensure
- FL State Medical License 2023 - 2026
- OH State Medical License 2005 - 2026
- IN State Medical License 2024 - 2025
- MN State Medical License 2024 - 2025
- TX State Medical License 2024 - 2025
- MI State Medical License 2004 - 2013
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Epilepsy
Clinical Trials
- International CDKL5 Clinical Research Network Start of enrollment: 2021 Feb 15
- A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome Start of enrollment: 2020 Sep 15
Publications & Presentations
PubMed
- 12 citationsInfluences on the trajectory and subsequent outcomes in CDKL5 deficiency disorder.Helen Leonard, Mohammed Junaid, Kingsley Wong, Alex A Aimetti, Elia M. Pestana Knight
Epilepsia. 2021-11-27 - Asymmetric eye movement artifacts on EEG, secondary to unilateral retinal detachment in patients with focal epilepsy.Karlo Toljan, Elia Pestana-Knight, Ahsan N.V. Moosa
Epileptic Disorders. 2021-10-12 - 14 citationsSurgical candidates in children with epileptic spasms can be selected without invasive monitoring: A report of 70 casesGozde Erdemir, Elia Pestana-Knight, Ryan Honomichl, Nicolas R. Thompson, Deepak Lachhwani
Epilepsy Research. 2021-10-01
Professional Memberships
- Member
- Child Neurology SocietyMember
- American Epilepsy SocietyFellow
- American Clinical Neurophysiology SocietyFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: